Evidence map›Paper›PMID 32620119›Full record

ArticleBMC musculoskeletal disorders2020

Association between musculoskeletal function deterioration and locomotive syndrome in the general elderly population: a Japanese cohort survey randomly sampled from a basic resident registry.

Ryosuke Tokida, Shota Ikegami, Jun Takahashi, Yoshikazu Ido, Ayaka Sato, Noriko Sakai, Hiroshi Horiuchi, Hiroyuki Kato

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Relationship between Components of Postural Control and Locomotive Syndrome in Older Adults.International journal of environmental research and public health · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Associations ofTherapeutics and clinical risk management · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ryosuke TokidaRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Shota IkegamiRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan. sh.ikegami@gmail.com.ORCID http://orcid.org/0000-0001-6404-5249
Jun TakahashiDepartment of Orthopaedic Surgery, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Yoshikazu IdoRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Ayaka SatoRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Noriko SakaiDepartment of Orthopaedic Surgery, New Life Hospital, Obuse, Kamitakai-gun, Nagano, 381-0295, Japan.
Hiroshi HoriuchiRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Hiroyuki KatoRehabilitation Center, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan.
Shinshu University Hospital · JPShinshu University · JPHeart Life Hospital · JP

Funding

The Japan Orthopaedics and Traumatology Research Foundation, Inc. 339
6 · The paper itself

Abstract

backgroundLocomotive syndrome (LoS) is defined as the loss of mobility due to age-related impairment of motor organs. The purpose of this study was to evaluate the prevalence and severity of LoS, muscular strength and balancing ability, and prevalence of sarcopenia in relation to the presence of LoS according to sex and age groups ranging between 50 and 89 years.

methodsMale and female participants between the ages of 50-89 were randomly selected in the resident registry of a cooperating town. Calls for participation continued until approximately 50 consenting participants were successfully recruited for each age group and sex. A total of 413 participants (203 male and 210 female) were enrolled for undergoing a LoS risk test and measuring their physical function. Physical function was compared to participants with or without LoS.

resultsA total of 312 patients (75.5%) were diagnosed as LoS, of which 144 (46.2%) were male and 168 (53.8%) were female. The severity of LoS for the 312 patients were 210 (67.3%) for stage 1 and 102 (32.7%) for stage 2. The prevalence of LoS in males were 37, 59, 91, and 100% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of LoS in females were 71, 62, 89, and 98% in the 50s, 60s, 70s, and 80s age strata, respectively. The prevalence of sarcopenia was significantly higher as the age strata in males grew higher. Knee extension strength was significantly lower for participants in their 50s and females in addition to females in their 60s with LoS. The 31 patients diagnosed as sarcopenia included 29 (93.5%) with LoS, 11 (35.4%) classified as LoS stage 1, and 18 (58.1%) classified as stage 2.

conclusionsThe prevalence of LoS was high in participants over 70 years of age. In males, the prevalence of sarcopenia was higher as the age strata grew higher. Patients with LoS exhibited lower knee extension strength. We believe that some measures to prevent or improve LoS may require exercise to increase the muscle strength of the lower limbs.

Indexed as

SyndromeAgedAged, 80 and overCohort StudiesCross-Sectional StudiesDisability EvaluationFemaleGeriatric AssessmentHumansJapanLocomotionMaleMiddle AgedMobility LimitationPhysical ExaminationPrevalenceCross-sectional surveyEpidemiological studyLocomotion, physical examinationPrevalenceSarcopenia

Identifiers

PMID32620119
PMCPMC7334862
OpenAlexW3038136497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.